TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,708 | -30.0% | 7,238 | +20.3% | 0.00% | 0.0% |
| Q2 2023 | $92,406 | -16.9% | 6,016 | +21.7% | 0.00% | -25.0% |
| Q1 2023 | $111,146 | +14.1% | 4,942 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $97,447 | -11.4% | 4,501 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $110,000 | +0.9% | 4,501 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $109,000 | -6.0% | 4,501 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $116,000 | -17.1% | 4,501 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $140,000 | +28.4% | 4,501 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $109,000 | +65.2% | 4,501 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $66,000 | -41.1% | 4,501 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $112,000 | -1.8% | 4,501 | +8.0% | 0.00% | -20.0% |
| Q4 2020 | $114,000 | – | 4,169 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |